[Ocular changes in rheumatic disease].
D000293:Adolescent; D000305:Adrenal Cortex Hormones / Q000009:adverse effects* / Q000627:therapeutic use; D000893:Anti-Inflammatory Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001171:Arthritis, Juvenile / Q000150:complications; D002386:Cataract / Q000139:chemically induced; D002648:Child; D002675:Child, Preschool; D003316:Corneal Diseases / Q000139:chemically induced / Q000209:etiology; D004342:Drug Hypersensitivity; D005128:Eye Diseases / Q000139:chemically induced / Q000209:etiology*; D005901:Glaucoma / Q000139:chemically induced; D006801:Humans; D007500:Iritis / Q000209:etiology; D007637:Keratoconjunctivitis / Q000139:chemically induced; D010211:Papilledema / Q000139:chemically induced; D012164:Retinal Diseases / Q000139:chemically induced; D012216:Rheumatic Diseases / Q000150:complications* / Q000188:drug therapy; D012859:Sjogren's Syndrome / Q000209:etiology
D000305:Adrenal Cortex Hormones; D000893:Anti-Inflammatory Agents
Alterazioni oculari in corso di malattie reumatiche.